Table 3.
Outcomes Among Patients With Week 2 Ki67 of ≤ 10% or Not Determined Who Continued on Neoadjuvant Aromatase Inhibitor
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.